Alaunos Therapeutics | ZIOP - Operating Expenses



Alaunos Therapeutics reported $759K in Operating Expenses for its fiscal quarter ending in December of 2024.


Operating Expenses Change Date
Adcock Ingram Holdings ZAR 4.23B 196.72M Dec/2024
Alaunos Therapeutics USD 759K 391K Dec/2024
Amgen USD 6.52B 337M Jun/2025
AstraZeneca USD 10.95B 1.04B Jun/2025
Baxter International USD 2.54B 29M Jun/2025
Biogen USD 1.79B 326.1M Jun/2025
Bioline Rx USD 2.61M 36K Jun/2025
Bristol-Myers Squibb USD 8.5B 265M Jun/2025
Celltrion KRW 718.99B 24.68B Jun/2025
Corcept Therapeutics USD 167.76M 13.96M Jun/2025
Cspc Pharmaceutical CNY 5.22B 248.9M Mar/2025
Dianthus Therapeutics USD 35.12M 1.88M Jun/2025
Divis Laboratories Ltd 17.93B 130M Jun/2025
Gilead Sciences USD 4.35B 80M Jun/2025
GlaxoSmithKline GBP 5.96B 663M Jun/2025
Incyte USD 904.7M 56.97M Jun/2025
Ionis Pharmaceuticals USD 312.21M 34.21M Jun/2025
J&J USD 16.8B 8.54B Jun/2025
Kangmei Pharma CNY 1.25B 35.75M Jun/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Laboratorios Farma EUR 132.33M 179.02M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 19.8M 9.46M Dec/2024
Merck USD 9.44B 217M Jun/2025
Neuren Pharmaceuticals AUD 17.41M 2.86M Dec/2024
Novartis USD 9.97B 1.02B Jun/2025
Organigram Holdings CAD 72.9M 18.86M Jun/2025
Pfizer USD 11.62B 1.58B Jun/2025
Pharma Mar EUR 32.29M 9.66M Jun/2025
PTC Therapeutics USD 213.73M 7.86M Jun/2025
Qiagen NV USD 397.57M 39.27M Jun/2025
Regeneron Pharmaceuticals USD 2.6B 159.1M Jun/2025
Roche Holding CHF 11.43B 1.48B Dec/2024
Sartorius EUR 722.5M 23.1M Jun/2025
Sino Biopharmaceutical CNY 11.66B 352.34M Dec/2024
TG Therapeutics USD 106.3M 5.93M Jun/2025
Tilray USD 253.17M 16.55M Nov/2024
Zz Pientze Pharmaceu 1.68B 272.39M Jun/2025